Stock listing

BMV:ORYN Oryzon Genomics SA Acciones

Mexican listing (BMV) of Oryzon Genomics SA · home listing BME:ORY

Follow Oryzon Genomics SA into a list and get an email when it puts out news.

Home listing price · BME:ORY

€2.41 EUR +0.09 (+3.9%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, BME:ORY

Past year -20.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
€2.39 – €2.49 EURNov 20, 2026
Volume
376,082 sharesNov 20, 2026
Market cap
€197.2M EURAt the close on Nov 20, 2026 · price × 81.96M shares outstanding
52-week range
€2.23 – €3.56 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€505,710 EURMedian day 122,871 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Oryzon Genomics SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
BME:ORY · Home€2.406 EUR+0.09 (+3.9%)376,082€2.408€2.49€2.386€2.316Close on Nov 20, 2026
LSE:0RDB€2.42 EUR-0.096 (-3.8%)2,088€2.458€2.458€2.42€2.516Close on Nov 20, 2026
Frankfurt:ORN€2.376 EUR-0.004 (-0.2%)—€2.376€2.376€2.376€2.38Close on Nov 20, 2026
Stuttgart:ORN€2.372 EUR-0.054 (-2.2%)—€2.41€2.464€2.372€2.426Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · BME:ORY · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€2.406+0.09+3.9%€2.408€2.49€2.386376,082
€2.3160.000.0%€2.312€2.34€2.30699,949
€2.316-0.02-0.9%€2.342€2.362€2.292120,627
€2.336-0.01-0.4%€2.30€2.48€2.23735,313
€2.346-0.23-8.9%€2.598€2.598€2.321,246,862
€2.576+0.102+4.1%€2.578€2.59€2.514355,206
€2.474+0.048+2.0%€2.422€2.494€2.402194,878
€2.426+0.048+2.0%€2.39€2.47€2.39321,112
€2.378+0.046+2.0%€2.362€2.39€2.286433,133
€2.332-0.022-0.9%€2.374€2.40€2.324260,525
€2.354-0.038-1.6%€2.438€2.474€2.354287,153
€2.3920.000.0%€2.388€2.42€2.382152,469
€2.392+0.052+2.2%€2.33€2.514€2.31528,206
€2.34-0.088-3.6%€2.388€2.42€2.302564,066
€2.428-0.07-2.8%€2.49€2.506€2.404178,481
€2.498+0.004+0.2%€2.484€2.518€2.48482,005
€2.494-0.016-0.6%€2.512€2.534€2.48121,183
€2.51+0.01+0.4%€2.53€2.532€2.4999,097
€2.500.000.0%€2.504€2.522€2.49498,723
€2.50-0.03-1.2%€2.54€2.556€2.486123,421
€2.53-0.072-2.8%€2.592€2.596€2.53113,036
€2.602+0.022+0.9%€2.55€2.61€2.5590,954
€2.58+0.056+2.2%€2.512€2.594€2.504151,201
€2.524-0.024-0.9%€2.554€2.558€2.512106,442
€2.548-0.006-0.2%€2.524€2.58€2.522107,645
€2.554-0.018-0.7%€2.58€2.58€2.492266,940
€2.572+0.04+1.6%€2.546€2.61€2.52307,467
€2.532-0.146-5.5%€2.646€2.664€2.48619,616
€2.678+0.028+1.1%€2.674€2.69€2.65673,218
€2.65+0.02+0.8%€2.64€2.694€2.60188,889
€2.63-0.07-2.6%€2.698€2.698€2.60243,876
€2.70-0.018-0.7%€2.708€2.718€2.6859,792
€2.718+0.018+0.7%€2.69€2.738€2.672273,107
€2.70-0.032-1.2%€2.75€2.756€2.68220,508
€2.732-0.022-0.8%€2.75€2.75€2.71285,250
€2.754-0.024-0.9%€2.758€2.774€2.7181,838
€2.778+0.068+2.5%€2.71€2.78€2.71190,927
€2.71-0.04-1.5%€2.75€2.756€2.71164,753
€2.75+0.018+0.7%€2.76€2.808€2.73216,114
€2.732+0.002+0.1%€2.72€2.76€2.7291,297
€2.73-0.002-0.1%€2.76€2.76€2.69201,664
€2.732-0.064-2.3%€2.79€2.792€2.73173,197
€2.796+0.02+0.7%€2.78€2.818€2.77455,682
€2.776-0.012-0.4%€2.772€2.788€2.75238,387
€2.788-0.024-0.9%€2.828€2.828€2.7755,352
€2.812+0.01+0.4%€2.814€2.83€2.8060,078
€2.802+0.008+0.3%€2.82€2.82€2.77834,500
€2.794+0.02+0.7%€2.798€2.814€2.7689,990
€2.774-0.014-0.5%€2.82€2.82€2.76463,495
€2.788-0.008-0.3%€2.79€2.808€2.7896,764
€2.796+0.022+0.8%€2.77€2.816€2.7771,303
€2.774-0.036-1.3%€2.83€2.83€2.7788,446
€2.81+0.022+0.8%€2.82€2.838€2.80200,980
€2.788-0.006-0.2%€2.80€2.804€2.76480,395
€2.794-0.018-0.6%€2.82€2.82€2.7957,828
€2.8120.000.0%€2.78€2.848€2.7844,253
€2.812+0.02+0.7%€2.814€2.84€2.762109,055
€2.792-0.006-0.2%€2.798€2.808€2.766110,204
€2.798-0.012-0.4%€2.87€2.87€2.794171,317
€2.81-0.01-0.4%€2.83€2.878€2.75367,327
€2.82-0.02-0.7%€2.864€2.864€2.818130,044
€2.84-0.016-0.6%€2.864€2.868€2.8472,811
€2.856+0.02+0.7%€2.82€2.874€2.8274,075
€2.836-0.018-0.6%€2.878€2.878€2.812122,320
€2.854+0.066+2.4%€2.81€2.88€2.788201,092
€2.788-0.038-1.3%€2.88€2.88€2.784275,559
Ticker
BMV:ORY/N
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BMV
Currency
MXN

What changed lately

Latest news

All Oryzon Genomics SA news

Financings

  • Shares (capital increase)

    Jul 27, 2026 · US$13.65M

    Closed: €12M raised

    Use of proceeds: To support the pipeline through the clinical catalysts expected this year and beyond

    Closed Jul 27, 2026

  • Strategic investment of newly issued Oryzon shares

    Jul 27, 2026 · US$28.44M

    Update: €25M

    Buyers: Social Impact Fund (committed, as an anchor investor, to subscribe for newly issued shares for an aggregate investment of €25 million)

    Use of proceeds: To support Oryzon's mental health programs

    Update Jul 27, 2026

  • Private placement of new ordinary shares

    Jul 1, 2026 · US$13.7M

    Closed: €12M raised · €2.7 a share · Singular Bank +1

    Dealers: Singular Bank, All-Invest

    Use of proceeds: Strengthen balance sheet, advance iadademstat in AML, progress other hematology and psychiatry programs, cover G&A and financial obligations

    Closed Jul 1, 2026

  • Strategic investment of newly created Oryzon shares

    Jul 1, 2026 · US$28.53M

    Announced: €25M

    Buyers: Social Impact Fund (committed to subscribe for newly created shares for a total investment amount of €25 million)

    Use of proceeds: R&D in central nervous system, oncology and hematology; at least 40% to mental health programs, notably borderline personality disorder

    Announced Jul 1, 2026

  • Shares (capital increase through cash contributions)

    Dec 15, 2025 · US$146.9M

    Announced: up to €125M

    Announced Dec 15, 2025

  • Convertible bonds

    Jul 30, 2025

    Cancelled: convertible

    Buyers: Nice & Green, S.A.; Nice & Green

    Update Feb 28, 2025 · Cancelled Jul 30, 2025

  • Private placement of new shares

    Apr 24, 2025 · US$34.12M

    Closed: €30M raised · €2.35 a share · Maxim +2

    Dealers: Maxim (co-lead), All-Invest (co-lead), Singular Bank (co-lead)

    Buyers: US-based institutional investor (€15 million order)

    Use of proceeds: Clinical development of vafidemstat, oncology and hematology programs, CMC and Phase IIb-III preparation, balance sheet, general expenses, Nasdaq listing readiness

    Closed Apr 24, 2025

Read by 6ix AI from the company's releases

Decks

Oryzon Genomics SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
32 in the last 12 months · 174 in all · newest Nov 13, 2026 · oldest 2015
Decks
18 decks · latest March 2026

Where Oryzon Genomics SA is listed

ListingExchangeCountryCurrency
BME:ORY · Home listingMadridSpainEUR
gettex:ORNgettexGermanyEUR
LS Exchange:A2ACV2LS ExchangeGermanyEUR
LSE:0RDBLSEUnited KingdomEUR
OTC:ORYZFOTCUnited StatesUSD
Lang & Schwarz:A2ACV2Lang & SchwarzGermanyEUR
Aquis:ORYEAquisUnited KingdomEUR
BMV:ORYN · This pageBMVMexicoMXN
Tradegate:ORNTradegateGermanyEUR
Aquis:ORYEAquisUnited KingdomEUR
BIVA:ORYNBIVAMexicoMXN
Dusseldorf:ORNDusseldorfGermanyEUR
Frankfurt:ORNFrankfurtGermanyEUR
Hamburg:ORNHamburgGermanyEUR
Munich:ORNMunichGermanyEUR
Stuttgart:ORNStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Oryzon Genomics SA.